Dr. Horn on Monitoring Response and Resistance to Ensartinib in ALK+ NSCLC
April 11th 2019
Leora Horn, MD, MSc, associate professor of cancer research, Vanderbilt University Medical Center, discusses the use of circulating tumor DNA analysis as a means to monitor response to, as well as resistance to, ensartinib in patients with ALK–positive non–small cell lung cancer.